These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21735472)

  • 1. Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy.
    Teng CF; Wu HC; Tsai HW; Shiah HS; Huang W; Su IJ
    Hepatology; 2011 Oct; 54(4):1199-207. PubMed ID: 21735472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B Virus Pre-S2 Mutant Induces Aerobic Glycolysis through Mammalian Target of Rapamycin Signal Cascade.
    Teng CF; Hsieh WC; Wu HC; Lin YJ; Tsai HW; Huang W; Su IJ
    PLoS One; 2015; 10(4):e0122373. PubMed ID: 25909713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage.
    Hsieh YH; Su IJ; Wang HC; Chang WW; Lei HY; Lai MD; Chang WT; Huang W
    Carcinogenesis; 2004 Oct; 25(10):2023-32. PubMed ID: 15180947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis.
    Yang JC; Teng CF; Wu HC; Tsai HW; Chuang HC; Tsai TF; Hsu YH; Huang W; Wu LW; Su IJ
    Hepatology; 2009 Jun; 49(6):1962-71. PubMed ID: 19475690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
    Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
    Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis.
    Wu HC; Tsai HW; Teng CF; Hsieh WC; Lin YJ; Wang LH; Yuan Q; Su IJ
    Hum Pathol; 2014 Jun; 45(6):1294-301. PubMed ID: 24767856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
    Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
    J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus pre-S2 mutants and its implication in hepatocarcinogenesis.
    Wang LH; Huang W; Lai MD; Su IJ
    Carcinogenesis; 2012 Feb; 33(2):466-72. PubMed ID: 22159224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
    Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
    Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Teng CF; Wu HC; Shyu WC; Jeng LB; Su IJ
    Cell Transplant; 2017 Mar; 26(3):429-438. PubMed ID: 28195035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of HBV surface antigen gene expression by a lentiviral microRNA-based system inhibits HBV replication and HCC growth.
    Xiangji L; Feng X; Qingbao C; Weifeng T; Xiaoqing J; Baihe Z; Feng S; Hongyang W; Mengchao W
    J Viral Hepat; 2011 Sep; 18(9):653-60. PubMed ID: 20642484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.
    Paterlini P; Poussin K; Kew M; Franco D; Brechot C
    Hepatology; 1995 Feb; 21(2):313-21. PubMed ID: 7843699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression of hepatitis B surface antigen between hepatocellular carcinoma and its surrounding liver tissue, studied using a tissue microarray.
    Wang Y; Wu MC; Sham JS; Tai LS; Fang Y; Wu WQ; Xie D; Guan XY
    J Pathol; 2002 Aug; 197(5):610-6. PubMed ID: 12210080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection.
    Fan YF; Lu CC; Chen WC; Yao WJ; Wang HC; Chang TT; Lei HY; Shiau AL; Su IJ
    Hepatology; 2001 Jan; 33(1):277-86. PubMed ID: 11124846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.
    Su IJ; Wang LH; Hsieh WC; Wu HC; Teng CF; Tsai HW; Huang W
    J Biomed Sci; 2014 Oct; 21(1):98. PubMed ID: 25316153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
    Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
    J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases.
    Cabrerizo M; Bartolomé J; Caramelo C; Barril G; Carreno V
    Hepatology; 2000 Jul; 32(1):116-23. PubMed ID: 10869298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
    Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
    J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.